Quantification of albendazole in tablets of combined composition
DOI:
https://doi.org/10.15587/2519-4852.2020.211197Keywords:
albendazole, tablets, quantitative analysis, praziquantel, spectrophotometry, UV, validation, anthelmintic drugsAbstract
The aim. Treatment of helminthiases of the digestive system remains an actual task of the medicine and pharmacy worldwide. So, to meet the needs of the Ukrainian pharmaceutical market tablets based on albendazole and praziquantel were proposed. In order to establish the further production of the drug, studies were conducted on the development and validation of a method for the quantitative determination of one of the active substances – albendazole, in the presence of the second active substance praziquantel.
Materials and methods. The object of the study was samples of tablets under the conditional name “AP-helmin”. Albendazole was extracted from tablets with ethyl alcohol when heated, 0.1 M sodium hydroxide solution was added and the obtained sample was evaluated spectrophotometrically in the ultraviolet light (308 nm). The method was conducted meeting the requirements of State Pharmacopoeia of Ukraine, harmonized with the relevant European Pharmacopoeia techniques.
Results. The samples comply with the Bouguer-Lambert-Behr law in the concentration range 1 × 10-3 - 1.2 × 10-2 mg/ml, the correlation coefficient is ≥ 0.9998. The studied method of quantitative determination of albendazole in the drug meets the criteria of acceptability for the range of determination ± 5.0 % by validation characteristics: specificity, linearity, precision, accuracy.
The criterion of insignificance of the systematic error of the method is fulfilled – the systematic error of the method (0.24) is practically insignificant, that is, the method of analysis is characterized by sufficient correctness in the whole concentration range from 80 to 120 %. All the validation characteristics respond to the acceptance criteria.
Conclusions. A method for the quantitative determination of albendazole in tablets “AP-helmin” by spectrophotometry in ultraviolet light (308 nm) was worked out. It was experimentally confirmed that the second active pharmaceutical ingredient (praziquantel) had no affect the accuracy of the results obtained
References
- Fylyptsova, O. V., Naboka, O. Y. (2016). Parazyti, patoheni y chelovek. Kharkiv: Polosataia typohrafyia, 212.
- Horlenko, O. M., Poliak-Tovt, V. M., Poliak, M. A. (2013). Helmintozy: epidemiolohiia, klinika, diahnostyka ta likuvannia. Problemy klinichnoi pediatrii, 2 (20), 10–14.
- Semchenko, K., Vyshnevska, L., Polovko, N. (2018). Study of anthelmintic activity and acute toxicity of medicine of combined composition. ScienceRise: Pharmaceutical Science, 6 (16), 8–12. doi: http://doi.org/10.15587/2519-4852.2018.151428
- Semchenko K. V., Vyshnevska L. I. (2019). Pat. No. 142220 UA. Antyhelmintnyi zasib na osnovi albendazolu ta prazykvantelu. MPK: A61K 31/4184, A61K 31/47, A61P 33/00. No. u 2019 10233; declareted: 07.10.2019, published: 25.05.2020, Bul. No. 10.
- Semchenko K. V., Vyshnevska L. I. (2019). Antyhelmintnyi zasib na osnovi albendazolu ta prazykvantelu. MPK: (2019.1): A61K 31/4184, A61K 31/47, A61P 33/00. No. a201910236; declareted: 07.10.2019.
- Patel, C., Coulibaly, J. T., Schulz, J. D., N’Gbesso, Y., Hattendorf, J., Keiser, J. (2020). Efficacy and safety of ascending dosages of albendazole against Trichuris trichiura in preschool-aged children, school-aged children and adults: A multi-cohort randomized controlled trial. EClinicalMedicine, 22, 100335. doi: http://doi.org/10.1016/j.eclinm.2020.100335
- Sajid, M., Zaheer, A., Muhammad, A., Sonia, H., Abrar, H., Naresh, K. (2015). Method Development and Validation for the Estimation of Anthelmintic Drug (Albendazole) in Tablet Preparations. International Journal of Pharmaceutical Sciences Review and Research, 32 (1), 284–287.
- Refat, M. S., Mohamed, G. G., Fathi, A. (2011). Spectrophotometric Determination of Albendazole Drug in Tablets: Spectroscopic Characterization of the Charge-transfer Solid Complexes. Chinese Journal of Chemistry, 29 (2), 324–332. doi: http://doi.org/10.1002/cjoc.201190086
- Swamy, N., Basavaiah, K. (2014). Simple and rapid spectrophotometric assay of albendazole in pharmaceuticals using iodine and picric acid as CT complexing agents. Brazilian Journal of Pharmaceutical Sciences, 50 (4), 839–850. doi: http://doi.org/10.1590/s1984-82502014000400019
- Derzhavna Farmakopeia Ukrainy. Vol. 1 (2014). Kharkiv: Derzh. p-vo «Naukovo-ekspertnyi farmakopeinyi tsentr yakosti likarskykh zasobiv», 1128.
- European Pharmacopoeia (2020). Concil of Europe: EDQM.
- Soto, C., Contreras, D., Orellana, S., Yañez, J., Toral, M. I. (2010). Simultaneous Determination of Albendazole and Praziquantel by Second Derivative Spectrophotometry and Multivariated Calibration Methods in Veterinary Pharmaceutical Formulation. Analytical Sciences, 26 (8), 891–896. doi: http://doi.org/10.2116/analsci.26.891
- Baraka, M. M., Elsadek, M. E., Ibrahim, A. M. (2014). Spectrophotometric determination of albendazole in pure form and tablet form. Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry, 2 (4), 276–294.
- Ahmed, D. A., Abdel-Aziz, O., Abdel-Ghany, M., Weshahy, S. A. (2018). Stability indicating determination of Albendazole in bulk drug and pharmaceutical dosage form by chromatographic and spectrophotometric methods. Future Journal of Pharmaceutical Sciences, 4 (2), 161–165. doi: http://doi.org/10.1016/j.fjps.2018.02.001
- Schulz, J. D., Neodo, A., Coulibaly, J. T., Keiser, J. (2019). Pharmacokinetics of Albendazole, Albendazole Sulfoxide, and Albendazole Sulfone Determined from Plasma, Blood, Dried-Blood Spots, and Mitra Samples of Hookworm-Infected Adolescents. Antimicrobial Agents and Chemotherapy, 63 (4). doi: http://doi.org/10.1128/aac.02489-18
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Kateryna Valentynivna Semchenko, Liliia Ivanivna Vyshnevska
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.